Literature DB >> 31914842

CD3D is associated with immune checkpoints and predicts favorable clinical outcome in colon cancer.

Yi Yang1, Yiwen Zang1, Chuang Zheng1, Zhenyang Li1, Xiaodong Gu1, Minwei Zhou1, Zihao Wang1, Jianbin Xiang1, Zongyou Chen1, Yiming Zhou1.   

Abstract

Aim: The T cell receptor-CD3 complex has shown great potential in tumor therapy. However, there is currently no research on CD3D in tumors. Materials & methods: Correlation between CD3D expression and clinical parameters and immune checkpoints of of colon adenocarcinoma (COAD) were analyzed.
Results: CD3D decreased with increasing clinical stage and microsatellite status of COAD. Functional enrichment analysis revealed that CD3D is related to immune activation and regulation. Coexpression analysis indicated that CD3D is correlated with immune checkpoint and immune-infiltrated cells. Patients with higher expression of CD3D showed better clinical outcome.
Conclusion: The findings suggest that the participation of CD3D may serve as a prognostic marker of COAD and may act as a guide in the development of immunotherapy.

Entities:  

Keywords:  CD3D; COAD; immune; survival

Mesh:

Substances:

Year:  2020        PMID: 31914842     DOI: 10.2217/imt-2019-0145

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  9 in total

1.  Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma.

Authors:  Silvia Muccioli; Roberto Ciaccio; Valentina Brillo; Luigi Leanza
Journal:  Cell Death Discov       Date:  2022-06-20

2.  CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer.

Authors:  Li Yuan; Jingli Xu; Yunfu Shi; Zhiyuan Jin; Zhehan Bao; Pengcheng Yu; Yi Wang; Yuhang Xia; Jiangjiang Qin; Bo Zhang; Qinghua Yao
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

3.  Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.

Authors:  Zhipeng Zhu; Weipeng Ye; Xiaofang Wu; Sihao Lin; Jiuhua Xu; Lulu Li; Jiayi Li; Haibin Wang; Zhengjie Huang
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

4.  CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma.

Authors:  Zhengyu Wei; Yiming Shen; Chongchang Zhou; Yujie Cao; Hongxia Deng; Zhisen Shen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.

Authors:  Jeffrey Schlom; Sofia R Gameiro; Christine M Minnar; Paul L Chariou; Lucas A Horn; Kristin C Hicks; Claudia Palena
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

6.  A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancer.

Authors:  Jingshuai Wang; Xuemin Gu; Leilei Cao; Yiqin Ouyang; Xiao Qi; Zhijie Wang; Jianjun Wang
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

7.  Utilizing single-cell RNA sequencing for analyzing the characteristics of PBMC in patients with Kawasaki disease.

Authors:  Xue Fan; Yuhan Zhou; Xin Guo; Mingguo Xu
Journal:  BMC Pediatr       Date:  2021-06-14       Impact factor: 2.125

8.  Orexin A Suppresses the Expression of Exosomal PD-L1 in Colon Cancer and Promotes T Cell Activity by Inhibiting JAK2/STAT3 Signaling Pathway.

Authors:  Jing Wen; Xiaocen Chang; Bowen Bai; Qian Gao; Yuyan Zhao
Journal:  Dig Dis Sci       Date:  2021-06-07       Impact factor: 3.487

9.  Transcriptomic Analysis Reveals Host miRNAs Correlated with Immune Gene Dysregulation during Fatal Disease Progression in the Ebola Virus Cynomolgus Macaque Disease Model.

Authors:  Christopher P Stefan; Catherine E Arnold; Charles J Shoemaker; Elizabeth E Zumbrun; Louis A Altamura; Christina E Douglas; Cheryl L Taylor-Howell; Amanda S Graham; Korey L Delp; Candace D Blancett; Keersten M Ricks; Scott P Olschner; Joshua D Shamblin; Suzanne E Wollen; Justine M Zelko; Holly A Bloomfield; Thomas R Sprague; Heather L Esham; Timothy D Minogue
Journal:  Microorganisms       Date:  2021-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.